Suppr超能文献

评估使用全剂量与半剂量灭活脊髓灰质炎疫苗为儿童接种疫苗的人均成本。

Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine.

作者信息

Mvundura Mercy, Hsu Jui-Shan, Frivold Collrane, Kristensen Debra, Boyle Shanda, Zehrung Darin, Jarrahian Courtney

机构信息

PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.

PATH, Rue de Varembé 7, 1202 Geneva, Switzerland.

出版信息

Vaccine X. 2019 Jul 15;2:100032. doi: 10.1016/j.jvacx.2019.100032. eCollection 2019 Aug 9.

Abstract

INTRODUCTION

Inactivated poliovirus vaccine (IPV) shortages and evidence of improved immunogenicity of two intradermal (ID) fractional IPV (fIPV) doses compared with one full intramuscular dose led to recommendations for fIPV delivery. To provide evidence on the economics of fIPV, we estimated the cost per child vaccinated using full-dose IPV compared with fIPV in routine and campaign settings. We evaluated the impact on costs of alternative devices facilitating ID administration, vaccine vial sizes, and prices.

METHODS

We used an Excel-based model to estimate the commodity and delivery costs for providing IPV. Commodity costs included vaccine price per dose adjusted for wastage, prices for vaccine administration devices, and safety boxes. Delivery costs included storage costs at each level of the supply chain, transport costs for commodities between levels, and human resource costs for vaccine administration. Model inputs were obtained from various databases and published literature. All costs are reported in 2018 US dollars.

RESULTS

In both campaign and routine settings, fIPV had a lower cost per child vaccinated than full dosing, despite the assumed higher vaccine wastage with fIPV in routine settings, and even when novel ID administration devices were used. In routine settings, costs per child fully vaccinated with fractional doses were 15% to 48% lower than those with full-dose delivery across different vial sizes. The cost per child vaccinated ranged from $1.84 to $2.65 for fractional doses, depending on the administration device, compared with $3.57 for full dose, when using 5-dose vials. The magnitude of cost reductions with fIPV relative to full-dose IPV was largest with smaller vial sizes and higher vaccine price.

CONCLUSION

Adopting fIPV can reduce costs per child vaccinated compared with using full doses, especially as IPV prices increase in the short term and more so when two full doses could be recommended in the future.

摘要

引言

灭活脊髓灰质炎疫苗(IPV)短缺,且有证据表明两剂皮内(ID)分次IPV(fIPV)的免疫原性优于一剂完整肌内注射剂量,这促使人们推荐使用fIPV。为了提供fIPV的经济学证据,我们估计了在常规和群体性预防接种环境中,使用全剂量IPV与fIPV为儿童接种疫苗的人均成本。我们评估了替代的ID接种辅助设备、疫苗瓶规格和价格对成本的影响。

方法

我们使用基于Excel的模型来估计提供IPV的商品和接种成本。商品成本包括根据损耗调整后的每剂疫苗价格、疫苗接种设备价格和安全盒价格。接种成本包括供应链各环节存储成本、各环节间商品运输成本以及疫苗接种的人力资源成本。模型输入数据来自各种数据库和已发表文献。所有成本均以2018年美元报告。

结果

在群体性预防接种和常规环境中,尽管在常规环境中假设fIPV的疫苗损耗更高,甚至在使用新型ID接种辅助设备时,fIPV为儿童接种疫苗的人均成本仍低于全剂量接种。在常规环境中,不同规格疫苗瓶的分次剂量全程接种儿童的人均成本比全剂量接种低15%至48%。使用5剂疫苗瓶时,分次剂量接种儿童的人均成本在1.84美元至2.65美元之间,具体取决于接种设备,而全剂量接种为3.57美元。相对于全剂量IPV,fIPV成本降低幅度在较小规格疫苗瓶和较高疫苗价格时最大。

结论

与使用全剂量疫苗相比,采用fIPV可降低儿童接种疫苗的人均成本,特别是在短期内IPV价格上涨时,以及未来可能推荐接种两剂全剂量疫苗的情况下,成本降低更为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ac/6668218/5a6a656723cb/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验